Literature DB >> 23924955

Increased virulence of neuraminidase inhibitor-resistant pandemic H1N1 virus in mice: potential emergence of drug-resistant and virulent variants.

Min-Suk Song1, Yun Hee Baek, Eun-Ha Kim, Su-Jin Park, Semi Kim, Gyo-Jin Lim, Hyeok-Il Kwon, Philippe Noriel Q Pascua, Arun G Decano, Byeong-Jae Lee, Young-Il Kim, Richard J Webby, Young-Ki Choi.   

Abstract

Pandemic H1N1 2009 (A[H1N1]pdm09) variants associated with oseltamivir resistance have emerged with a histidine-to-tyrosine substitution in the neuraminidase(NA) at position 274 (H274Y). To determine whether the H274Y variant has increased virulence potential, A(H1N1)pdm09 virus, with or without the H274Y mutation, was adapted by serial lung-to-lung passages in mice. The mouse-adapted H274Y (maCA04H274Y) variants showed increased growth properties and virulence in vitro and in vivo while maintaining high NA inhibitor resistance. Interestingly, most maCA04H274Y and maCA04 viruses acquired common mutations in HA (S183P and D222G) and NP (D101G), while only maCA04H274Y viruses had consensus additional K153E mutation in the HA gene, suggesting a potential association with the H274Y substitution. Collectively, our findings highlight the potential emergence of A(H1N1)pdm09 drug-resistant variants with increased virulence and the need for rapid development of novel antiviral drugs.

Entities:  

Keywords:  drug resistance; mouse adaptation; neuraminidase; pandemic influenza; virulence

Mesh:

Substances:

Year:  2013        PMID: 23924955      PMCID: PMC5359727          DOI: 10.4161/viru.25952

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  23 in total

1.  Generation and characterization of recombinant pandemic influenza A(H1N1) viruses resistant to neuraminidase inhibitors.

Authors:  Andrés Pizzorno; Xavier Bouhy; Yacine Abed; Guy Boivin
Journal:  J Infect Dis       Date:  2011-01-01       Impact factor: 5.226

2.  Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus.

Authors:  Erhard van der Vries; Foekje F Stelma; Charles A B Boucher
Journal:  N Engl J Med       Date:  2010-09-30       Impact factor: 91.245

3.  Neuraminidase H275Y and hemagglutinin D222G mutations in a fatal case of 2009 pandemic influenza A (H1N1) virus infection.

Authors:  Aaron DeVries; Jason Wotton; Christine Lees; David Boxrud; Timothy Uyeki; Ruth Lynfield
Journal:  Influenza Other Respir Viruses       Date:  2012-01-14       Impact factor: 4.380

4.  Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate.

Authors:  M Potier; L Mameli; M Bélisle; L Dallaire; S B Melançon
Journal:  Anal Biochem       Date:  1979-04-15       Impact factor: 3.365

5.  Molecular characterization of pandemic H1N1 influenza viruses isolated from turkeys and pathogenicity of a human pH1N1 isolate in turkeys.

Authors:  Yohannes Berhane; Davor Ojkic; James Neufeld; Marsha Leith; Tamiko Hisanaga; Helen Kehler; Arpad Ferencz; Helen Wojcinski; Colleen Cottam-Birt; Matthew Suderman; Katherine Handel; Soren Alexandersen; John Pasick
Journal:  Avian Dis       Date:  2010-12       Impact factor: 1.577

6.  Escape mutants of pandemic influenza A/H1N1 2009 virus: variations in antigenic specificity and receptor affinity of the hemagglutinin.

Authors:  Irina Rudneva; Anna Ignatieva; Tatiana Timofeeva; Aleksandr Shilov; Alla Kushch; Olga Masalova; Regina Klimova; Nicolai Bovin; Larisa Mochalova; Nikolai Kaverin
Journal:  Virus Res       Date:  2012-03-21       Impact factor: 3.303

7.  Variations in the hemagglutinin of the 2009 H1N1 pandemic virus: potential for strains with altered virulence phenotype?

Authors:  Jianqiang Ye; Erin M Sorrell; Yibin Cai; Hongxia Shao; Kemin Xu; Lindomar Pena; Danielle Hickman; Haichen Song; Matthew Angel; Rafael A Medina; Balaji Manicassamy; Adolfo Garcia-Sastre; Daniel R Perez
Journal:  PLoS Pathog       Date:  2010-10-14       Impact factor: 6.823

8.  Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.

Authors:  Tiffany G Sheu; Varough M Deyde; Margaret Okomo-Adhiambo; Rebecca J Garten; Xiyan Xu; Rick A Bright; Eboneé N Butler; Teresa R Wallis; Alexander I Klimov; Larisa V Gubareva
Journal:  Antimicrob Agents Chemother       Date:  2008-07-14       Impact factor: 5.191

9.  The polymerase acidic protein gene of influenza a virus contributes to pathogenicity in a mouse model.

Authors:  Min-Suk Song; Philippe Noriel Q Pascua; Jun Han Lee; Yun Hee Baek; Ok-Jun Lee; Chul-Joong Kim; Hyunggee Kim; Richard J Webby; Robert G Webster; Young Ki Choi
Journal:  J Virol       Date:  2009-09-30       Impact factor: 5.103

10.  Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses.

Authors:  Maki Kiso; Kyoko Shinya; Masayuki Shimojima; Ryo Takano; Kei Takahashi; Hiroaki Katsura; Satoshi Kakugawa; Mai Thi Quynh Le; Makoto Yamashita; Yousuke Furuta; Makoto Ozawa; Yoshihiro Kawaoka
Journal:  PLoS Pathog       Date:  2010-08-26       Impact factor: 6.823

View more
  2 in total

Review 1.  Molecular determinants of influenza virus pathogenesis in mice.

Authors:  Ram P Kamal; Jaqueline M Katz; Ian A York
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

2.  Differential Biphasic Transcriptional Host Response Associated with Coevolution of Hemagglutinin Quasispecies of Influenza A Virus.

Authors:  Himanshu Manchanda; Nora Seidel; Markus F Blaess; Ralf A Claus; Joerg Linde; Hortense Slevogt; Andreas Sauerbrei; Reinhard Guthke; Michaela Schmidtke
Journal:  Front Microbiol       Date:  2016-08-03       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.